收藏切换
Polysaccharide iron complex for the treatment of iron deficiency anemia: meta-analysis and cost analysis
收藏切换
Jian MING1, 2, Wei CHEN2, Min JIN2, Guanqi HONG2, Jingya WU2, Shanlian HU1, *
World Clinical Drug | 2022, 43(7) : 900 - 910
Less
收藏切换
World Clinical Drug | 2022, 43(7): 900-910
• Article •
Polysaccharide iron complex for the treatment of iron deficiency anemia: meta-analysis and cost analysis
Full
Jian MING1, 2, Wei CHEN2, Min JIN2, Guanqi HONG2, Jingya WU2, Shanlian HU1, *
Affiliations
  • 1.School of Public Health, Fudan University, Shanghai 200032, China
  • 2.Real World Solutions, IQVIA, Shanghai 200041, China
Published: 2022-07-10 doi: 10.13683/j.wph.2022.07.016
Outline
收藏切换
Objective

To evaluate the comparative efficacy and economic value of polysaccharide iron complex (PIC) and other oral iron supplements (ferrous sulfate, ferrous succinate, iron dextran) in treating iron deficiency anemia (IDA) patients.

Methods

Published clinical studies of PIC and other oral iron supplements in the treatment of chronic kidney disease (CKD) complicated with IDA, IDA patients during pregnancy, and children with IDA were systematically searched. Meta-analysis was performed to analyze the clinical efficacy. A decision tree model was constructed to perform cost analysis.

Results

A total of 169 studies were identified, and 22 studies were finally included. For CKD patients with IDA, PIC had higher effective rate (94% vs 87% vs 85%) and lower adverse event (AE) rate (19% vs 84% vs 88%) compared to ferrous sulfate and ferrous succinate. The average total treatment cost per patient was decreased by ¥535 (14%) and ¥1 839 (36%) respectively in a 12-month treatment course. For pregnant IDA patients, PIC had higher effective rate (95% vs 77% vs 80% vs 77%) and lower AE rate (6% vs 38% vs 9% vs 21%) compared to ferrous sulfate, ferrous succinate and iron dextran. The average total treatment cost was decreased by ¥270 (17%), ¥654 (33%) and 3 024 (70%) respectively in a 5-month treatment course. For children with IDA, PIC had higher effective rate (91% vs 84%) and lower AE rate (8% vs 51%) compared to ferrous sulfate and exhibited a cost saving of ¥119 (14%) in a 3-month treatment course. Results of sensitivity analysis supported the robustness of the findings.

Conclusion

For all three types of IDA populations, PIC demonstrated better clinical efficacy and produced cost savings in comparison to other oral iron supplements.

polysaccharide iron complex  /  iron deficiency anemia  /  systematic review  /  meta-analysis  /  cost analysis
明坚, 陈炜, 金敏, 洪冠琪, 吴静雅, 胡善联. 多糖铁复合物治疗缺铁性贫血的meta分析与成本研究. 世界临床药物, 2022 , 43 (7) : 900 -910 . DOI: 10.13683/j.wph.2022.07.016
Jian MING, Wei CHEN, Min JIN, Guanqi HONG, Jingya WU, Shanlian HU. Polysaccharide iron complex for the treatment of iron deficiency anemia: meta-analysis and cost analysis[J]. World Clinical Drug, 2022 , 43 (7) : 900 -910 . DOI: 10.13683/j.wph.2022.07.016
Year 2022 volume 43 Issue 7
18
7
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.07.016
  • Receive Date:2022-01-08
  • Online Date:2026-11-19
  • Published:2022-07-10
Article Data
Affiliations
History
  • Received:2022-01-08
Affiliations
    1.School of Public Health, Fudan University, Shanghai 200032, China
    2.Real World Solutions, IQVIA, Shanghai 200041, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.016
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT